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Abstract
Objective Axial osteoarthritis (OA) is a common cause of back and neck pain, however, few studies have examined its 
prevalence. The aim was to estimate the prevalence and the characteristics of symptomatic axial OA in Spain.
Methods EPISER2016 is a cross-sectional multicenter population-based study of people aged 40 years or older. Subjects 
were randomly selected using multistage stratified cluster sampling. Participants were contacted by telephone to complete 
rheumatic disease screening questionnaires. Two phenotypes were analyzed, patients with Non-exclusive axial OA (NEA-
OA) and Exclusive axial OA (EA-OA). To calculate the prevalence and its 95% confidence interval (CI), the sample design 
was considered and weighting was calculated according to age, sex and geographic origin.
Results Prevalence of NEA-OA by clinical or clinical-radiographic criteria was 19.17% (95% CI: 17.82–20.59). The fre-
quency of NEA-OA increased with age (being 3.6 times more likely in patients aged 80 s or more than in those between 40 
and 49 years) and body mass index. It was significantly more frequent in women, as well as in the center of Spain. It was less 
frequent in those with a higher level of education. Lumbar OA was more frequent than cervical OA. This difference grew 
with increasing age and was not associated with gender. It was also greater in overweight and obese subjects.
Conclusions This is the first study on the prevalence of axial OA phenotypes in Europe describing the associated socio-
demographic, anthropometric, and lifestyle variables.
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Introduction
Osteoarthritis (OA) is a heterogeneous group of diseases 
with similar clinical manifestations and sharing common 
pathological and radiological changes. Previously OA was 
described as a single disease, but this is not entirely correct. 
OARSI has recently defined OA as a disorder that affects 
movable joints, one characterized by cell stress and deg-
radation of the extracellular matrix of cartilage that begins 
with the presence of micro and macro lesions that activate 
mal-adaptive repair responses, including pro-inflammatory 
pathways of innate immunity. The disease initially manifests 
as a molecular alteration (abnormal joint tissue metabolism), 
which is followed by anatomical and/or physiological altera-
tions (characterized by cartilage degradation, bone remod-
eling, osteophyte formation, joint inflammation and loss of 
normal function), which can culminate in the onset of the 
illness [1]. OA has been also described as joint dysfunction 
[2]. The joint would be like any other organ of the human 
body, such as the heart, with its specialized tissues that form 
a structure with specific functions.
Axial OA is a clinical and pathological dysfunction that 
involves the functional failure of the synovial facet joints. 
This failure process involves the whole joint, including the 
subchondral bone, cartilage, ligaments, capsule, synovium, 
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and periarticular paraspinal muscles and soft tissues [3]. 
Kirkaldy–Willis described the spinal degenerative cascade that 
affects the three joint complexes comprised of the interverte-
bral disk (front) and the lumbar zygapophyseal (facet) joints 
(posterior) [4]. While most patients experience an initial 
alteration in the anterior spinal structures, some individuals 
(10–20%) exhibit a pattern of isolated posterior degeneration 
without substantial loss of disk height. Increased age, body 
mass index and female sex may be related to posterior degen-
eration in these individuals [5].
About half of adults suffer from neck pain and two-thirds 
from lower back pain at some point in their lifetime [6, 7]. 
Axial OA is a common cause of back and neck pain, which in 
turn have an enormous global impact on the health-care sys-
tems and economies of developed countries [8, 9]. Lower back 
and neck pain were the leading global cause of disability in 
2015 in most countries [10] and they remain important causes 
of absenteeism and premature retirement [11].
There are few studies on the prevalence of axial OA, most 
of them from Eastern Asia (Korea, China and Japan). There 
are more publications about lumbar OA [12–17] than cervical 
OA [18], and some studies address both [19–21], although 
separately. In 2000 the Spanish Society of Rheumatology 
(SER) promoted the EPISER2000 study, which attempted 
to determine the prevalence of rheumatic diseases in people 
older than 20 years, although axial OA was not included. The 
prevalence in Spain of knee OA was estimated as 10.2% and 
that of hand OA 6.2% [22, 23]. The changes in socio-demo-
graphic characteristics and lifestyle habits that have occurred 
in recent years in Spain justified updating the epidemiological 
data, leading SER to promote the EPISER2016 study [24]. Our 
group has recently published partial results of this project [25], 
wherein the prevalence of symptomatic hand OA was 7.73%, 
knee OA was 13.83% and hip OA was 5.13%. This new pro-
ject also encompassed axial OA. Based on these findings, the 
main objective of this work was to describe the characteristics 
and the prevalence of symptomatic axial OA (cervical and 
lumbar) in Spain. To compare we established three groups of 
patients: (a) Non-exclusive axial OA (NEA-OA phenotype): 
patients with Axial OA (cervical and/or lumbar) with or with-
out a simultaneous peripheral OA; (b) Exclusive axial OA 
(EA-OA) phenotype: patients with Axial OA (cervical and/or 
lumbar) without a peripheral OA and c) Control: subjects aged 
40 or over without axial OA used to compared with NEA-OA 
(these subjects can have peripheral OA) and EA-OA pheno-
types (these subjects have not peripheral).
Patients and methods
The methods and characteristics of the sample from the 
EPISER2016 study have been previously described [24, 
26]. In summary, it is a population-based multicenter 
cross-sectional study to estimate the prevalence of 13 rheu-
matic diseases (rheumatoid arthritis, SLE, symptomatic 
OA of the hand, knee, hip, cervical, and lumbar spine, 
fibromyalgia, ankylosing spondylitis, psoriatic arthritis, 
Sjögren’s syndrome, gout, and symptomatic osteoporotic 
fracture) in the adult population (≥ 20 years old) in Spain. 
Assuming a Poisson distribution, a sample comprising 
4,000 individuals would enable a 95% confidence interval 
(CI) of 0.30–0.77 for a prevalence of 0.5% (expected for 
rheumatoid arthritis) and of 0.14–0.54 for a prevalence 
of 0.3% (expected for psoriatic arthritis). Assuming that 
missing values would reach 20%, it was deemed necessary 
to include around 5000 individuals.
A multistage stratified cluster random sampling was 
carried out based on rural/urban municipalities, sex and 
age in accordance with the population distribution in 
Spain. Resident subjects in 78 municipalities randomly 
selected from the 17 Spanish autonomous communities 
belonging to 21 reference area hospitals participated [26]. 
From November 2016 to October 2017, the participants 
in each municipality were contacted using random digit 
dialing and a computer-assisted telephone interviewing 
system (CATI) to conduct screening questionnaires. An 
external sociological research company with experience in 
the field of health care and with call center service (Ipsos 
España) implemented both the random selection of tele-
phone numbers in each municipality and the initial screen-
ing interviews. In the case of non-answered phone calls, 
a minimum of six attempts were made during different 
time frames. If after these attempts there was no answer or 
the subject refused to participate, another phone number 
within the same municipality was randomly selected [26].
Screening was based on two complementary paths for 
all of the participants (Fig. 1). If a participant reported 
having been diagnosed, his/her consent was requested so 
that the investigating rheumatologists from that municipal-
ity's reference hospital could confirm the diagnosis was in 
his/her clinical history. Participants who met the criteria 
of an initial screening based on their symptoms were also 
identified. Participants not previously diagnosed, but who 
had a positive result in that symptom-based screening, 
received a second telephone call from the investigating 
rheumatologist to evaluate the suspicion by means of a 
second questionnaire.
Those participants for whom such suspicion lingered after 
the second telephone call were given an appointment at their 
reference hospital to complete the diagnostic confirmation 
process (physical examination and additional tests). Those 
subjects who had completed the call center interview with 
a positive result for axial OA screening, but whose records 
remained inaccessible to the rheumatologist or who could 




The study of the prevalence of OA was limited to sub-
jects ≥ 40 years old.
A screening for symptoms of cervical or lumbar OA 
was considered positive if the individual had cervical or 
lumbar pain not due to trauma or overstrain of at least 
3 months' duration (although the pain may have fluctuated 
in intensity) and that was aggravated by neck movements, 
carrying weight or making efforts. If in the second phone 
call the subject confirmed the characteristics of the pain 
previously described in the first phone call, he/she was 
asked about previous radiographic test to study that pain 
and the results of it. Suspicion remained if the individual 
reported an abnormal result or no previous radiological 
test.
These pathologies did not involve criteria approved by a 
specific society or scientific group. Therefore, the following 
criteria were specifically defined for this study to diagnose 
cervical and lumbar OA: (1) Cervical or lumbar mechanical 
pain of more than 3 months' evolution; (2) Stiffness of less 
than 30 min or the absence of stiffness; (3) Vertebral osteo-
phytes or decreased intervertebral space with sclerosis of 
the vertebral endplates; (4) Sclerosis of the interapophyseal 
joints. The diagnosis was confirmed if two of the clinical 
criteria (1 and 2) and at least one of the radiological criteria 
(3 and 4) were met.
These criteria were used to confirm those cases not diag-
nosed before the study. In the case of previously diagnosed 
patients, no attempt was made to actively verify that they 
fulfilled the criteria according to their clinical history; 
clearly identified diagnoses were accepted irrespective of the 
criteria applied (clinical or clinical-radiographical) (Fig. 2).
Variables collected in the first phone questionnaire 
consisted of demographic characteristics (age by decades, 
sex, geographic area of Spain—North, Mediterranean and 
Canary Islands, and Center—, type of municipality—urban 
if at least one town exceeded 10,000 inhabitants—and edu-
cational level—basic, medium or higher), body mass index 
(BMI) (normal weight, low weight, overweight, obese), 
smoking, and alcohol intake.
Oral informed consent was required from all partici-
pants during the first telephone call and their approval 
was recorded on audio. Written informed consent was also 
requested from all subjects who came to the participat-
ing centers for physical examinations and additional tests. 
Approval was obtained from the Research Ethics Committee 
(REC) of Hospital Universitario de Canarias (approval num-
ber: Acta 12/2016), which acted as the reference REC, and 
from the RECs of those participating centers that required to 
approve the study locally. The study was performed in com-
pliance with the principles of the Declaration of Helsinki.
Statistical analysis
Three groups of patients were used in the statistical analy-
sis according these definitions: (a) Non-exclusive axial OA 
(NEA-OA phenotype): Patients with Axial OA (cervical and/
or lumbar) with or without a simultaneous peripheral OA. 
(b) Exclusive axial OA (EA-OA) phenotype: Patients with 
Fig. 1  Axial OA screening algorithm
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Axial OA (cervical and/or lumbar) without a peripheral OA. 
(c) Control: Subjects aged 40 or over without axial OA used 
to compared with NEA-OA (these subjects can have periph-
eral OA) and EA-OA phenotypes (these subjects have not 
peripheral).
Prevalence and its 95% CI were calculated in accordance 
with the design of the sample. The weights were calculated 
depending on the selection probability in each of the stages 
of the sampling, using as a reference the distribution of the 
population in Spain in 2016 according to Continuous Reg-
ister Statistics from the Spanish National Statistical Institute 
(www. ine. es). This weighting was calculated considering age 
(grouped by decades), sex, and geographic origin (3 areas 
were defined: North [Galicia + Asturias + Cantabria + País 
Vasco + Navarra + La Rioja], Mediterranean and Canary 
Islands [Cataluña + Comunidad Valenciana + Balearic 
Islands + Murcia + Andalucía + Canary Islands], and Center 
[Comunidad de Madrid + Castilla y León + Aragón + Cas-
tilla-La Mancha + Extremadura]). Based on these charac-
teristics, each individual in the sample represented a certain 
number of individuals in the population.
Finally, any associations between axial OA and 
socio-demographic, anthropometric and lifestyle vari-
ables included in the first telephone questionnaire were 
analyzed. First, a bivariate analysis was carried out to 
determine any associations between the disease and each 
of the variables. Subsequently, binary logistic regression 
models were constructed using those variables with a p 
value of < 0.2 in the bivariate analysis (age and sex were 
included in the model, regardless of the p value in the 
bivariate analysis). Statistical significance was defined as 
p < 0.05.
The analyses were performed using IBM SPSS Statistics 
v22.
Results
The EPISER2016 study sample for analyzing OA consisted 
of 3,336 subjects ≥ 40 years in age, among whom 48 were 
missing and 978 (29.32%) had peripheral and/or axial OA. 
The prevalence of OA in Spain, in one or more of the stud-
ied locations (hand, knee, hip, cervical and/or lumbar) was 
29.35% (95% CI: 27.77–30.97) [25]. The mean age of the 
OA cases was 64.72 years; 730 were women, 62.6% had 
undergone basic studies, 70.1% were overweight or obese, 
and 83.9% were ex-smokers or non-smokers (Table 1).
Fig. 2  Number of cervical and 






Axial OA with or without a simultaneous peripheral 
OA phenotype (NEA‑OA phenotype)
The number of cases with axial OA based on clinical or clin-
ical-radiographic criteria in EPISER2016 was 664, which 
represents a prevalence of 19.17% (95% CI: 17.82–20.59); 
by sex, this equated to 25.31% (23.45–27.26) in women and 
12.43% (10.56–14.57) in men.
There were 649 cases of axial OA that met clinical-
radiographic criteria. Of these, some of which involved 
peripheral OA, 77.8% were women and 79.4% lived in an 
urban environment (Table 1). Most subjects had a basic edu-
cational level (64.3%), were overweight or obese (68.7%) 
and did not refer toxic habits (57.8% were non-smokers and 
83.5% did not drink alcohol on a daily basis).
In the univariate analysis of cases with NEA-OA pheno-
type versus subjects aged 40 years or older without axial OA 
(although in both groups a number of patients had periph-
eral OA), the frequency of NEA-OA phenotype increased 
with age. In addition, it was more frequent in women, in 
inhabitants living in the center of Spain, as well as in peo-
ple with a basic educational level. NEA-OA phenotype was 
Table 1  Descriptive analysis of 
the subjects with OA
Total OA hand, knee, hip, cervical and/or lumbar OA, NEA-OA cervical and/or lumbar OA with or without 
peripheral OA, EA-OA cervical and/or lumbar OA without peripheral OA, SDU standard drink unit
Total OA NEA-OA EA-OA Exclusive cervical OA Exclusive lumbar OA
Age range (years)
 40–49 125 (12.8) 88 (13.6) 69 (21.6) 25 (21.2) 46 (14.8)
 50–59 242 (24.7) 165 (25.4) 110 (34.5) 41 (34.7) 82 (26.5)
 60–69 257 (26.3) 183 (28.2) 73 (22.9) 31 (26.3) 73 (23.5)
 70–79 201 (20.6) 125 (19.3) 40 (12.5) 12 (10.2) 63 (20.3)
  ≥ 80 153 (15.6) 88 (13.6) 27 (8.5) 9 (7.6) 46 (14.8)
Sex
 Men 248 (25.4) 144 (22.2) 83 (26.0) 31 (26.3) 77 (24.8)
 Women 730 (74.6) 505 (77.8) 236 (74.0) 87 (73.7) 233 (75.2)
Region of Spain
 North 259 (26.5) 171 (26.3) 85 (26.6) 27 (22.9) 96 (31)
 Mediterranean and 
Canary Islands
378 (38.7) 241 (37.1) 104 (32.6) 54 (45.8) 95 (30.6)
 Center 341 (34.9) 237 (36.5) 130 (40.8) 37 (31.4) 119 (38.4)
Type of municipality
 Rural 212 (21.7) 134 (20.6) 65 (20.4) 23 (19.5) 63 (20.3)
 Urban 766 (78.3) 515 (79.4) 254 (79.6) 95 (80.5) 247 (79.7)
Educational level
 Basic 611 (62.6) 417 (64.3) 175 (54.9) 67 (56.8) 188 (60.6)
 Medium 207 (21.2) 134 (20.6) 81 (25.4) 23 (19.5) 72 (23.2)
 Higher 158 (16.2) 98 (15.1) 63 (19.7) 28 (23.7) 50 (16.1)
Body mass index
 Normal weight 266 (29.4) 187 (31) 115 (37.3) 48 (42.9) 87 (30.2)
 Low weight 4 (0.4) 2 (0.3) 2 (0.6) 2 (1.8) 0
 Overweight 405 (44.8) 259 (43) 137 (44.5) 44 (39.3) 126 (43.8)
 Obese 229 (25.3) 155 (25.7) 54 (17.5) 18 (16.1) 75 (26)
Smoking
 Non-smoker 561 (57.4) 375 (57.8) 164 (51.4) 58 (49.2) 177 (57.1)
 Former smoker 259 (26.5) 161 (24.8) 82 (25.7) 29 (24.6) 82 (26.5)
 Smoker 143 (14.6) 106 (16.3) 69 (21.6) 31 (26.3) 45 (14.5)
 Occasional smoker 15 (1.5) 7 (1.1) 4 (1.3) 0 6 (1.9)
Alcohol (daily intake)
 0 SDU 797 (81.5) 542 (83.5) 270 (84.6) 100 (84.7) 260 (83.9)
 1 SDU 120 (12.3) 73 (11.2) 37 (11.6) 12 (10.2) 33 (10.6)
 2–3 SDUs 50 (5.1) 26 (4) 8 (2.5) 4 (3.4) 13 (4.2)
  ≥ 4 SDUs 11 (1.1) 8 (1.2) 4 (1.3) 2 (1.7) 4 (1.3)
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more common in those who were obese, non-smokers, and 
nondrinkers (Table 2).
In the multivariate analysis, the frequency of NEA-OA 
phenotype increased with age (being 3.6 times more likely 
in patients aged 80 s or older versus those between 40 and 
49 years) and BMI (Table 3). It was significantly more fre-
quent in women than in men, as well as in the center of 
Spain, versus the north or the Mediterranean area. NEA-OA 
phenotype was less frequent in those with a higher level of 
education. There was no association between NEA-OA phe-
notype and smoking, or with a rural or urban environment. 
A lower frequency of NEA-OA phenotype was observed in 
subjects consuming two or three standard drink units (SDU) 
of alcohol per day.
Axial OA without a peripheral OA (EA‑OA 
phenotype)
Cases with EA-OA phenotype (without peripheral OA) 
showed similar characteristics to NEA-OA phenotype 
(Table 1). Most were women (74%) and lived in urban areas 
Table 2  Univariate analysis of NEA-OA vs subjects without axial OA 
≥40 years old
SDU standard drink unit




Age range (years)  < 0.001
 40–49 88 (8.5) 950 (91.5)
 50–59 165 (20.1) 657 (79.9)
 60–69 183 (27.2) 491 (72.8)
 70–79 125 (27.5) 330 (72.5)
  ≥ 80 88 (30.1) 204 (69.9)
Sex  < 0.001
 Men 144 (12.1) 1046 (87.9)
 Women 505 (24.2) 1586 (75.8)
Region of Spain 0.001
 North 171 (18.4) 758 (81.6)
 Mediterranean and 
Canary Islands
241 (17.7) 1117 (82.3)
 Center 237 (23.8) 757 (76.2)
Type of municipality 0.049
 Rural 134 (17.3) 640 (82.7)
 Urban 515 (20.5) 1992 (79.5)
Educational level  < 0.001
 Basic 417 (27.4) 1107 (72.6)
 Medium 134 (17.0) 654 (83.0)
 Higher 98 (10.2) 867 (89.8)
Body mass index  < 0.001
 Normal weight 187 (15.0) 1061 (85.0)
 Low weight 2 (8.0) 23 (92.0)
 Overweight 259 (19.7) 1053 (80.3)
 Obese 155 (29.3) 374 (70.7)
Smoking habit  < 0.001
 Non-smoker 375 (23.6) 1212 (76.4)
 Former smoker 161 (15.8) 860 (84.2)
 Smoker 106 (17.2) 511 (82.8)
 Occasional smoker 7 (12.5) 49 (87.5)
Alcohol (daily intake) 0.001
 0 SDU 542 (21.0) 2042 (79.0)
 1 SDU 73 (18.3) 326 (81.7)
 2–3 SDUs 26 (10.4) 225 (89.6)
  ≥ 4 SDUs 8 (17.0) 39 (83.0)
Table 3  Multivariate analysis of NEA-OA vs subjects without axial 
OA ≥ 40 years old
SDU standard drink unit
OR (95% CI) p value
Age range (years)
 40–49
 50–59 2.156 (1.614; 2.880)  < 0.001
 60–69 3.008 (2.232; 4.054)  < 0.001
 70–79 2.809 (2.007; 3.931)  < 0.001
  ≥ 80 3.646 (2.465; 5.391)  < 0.001
Sex
 Women 2.025 (1.600; 2.563)  < 0.001
Region of Spain
 North
 Mediterranean and Canary 
Islands
0.944 (0.743; 1.199) 0.637
 Center 1.355 (1.059; 1.732) 0.015
Type of municipality
 Urban 1.202 (0.952; 1.519) 0.123
Educational level
 Basic
 Medium 0.740 (0.582; 0.940) 0.014
 Higher 0.461 (0.354; 0.599)  < 0.001
Body mass index
 Normal weight
 Low weight 0.427 (0.097; 1.891) 0.263
 Overweight 1.346 (1.080; 1.677) 0.008
 Obese 2.129 (1.639; 2.765)  < 0.001
Smoking habit
 Non-smoker
 Former smoker 0.839 (0.665; 1.059) 0.139
 Smoker 1.102 (0.839; 1.447) 0.484
 Occasional smoker 0.836 (0.363; 1.923) 0.673
Alcohol (daily intake)
 0 SDU
 1 SDU 0.904 (0.667; 1.225) 0.516
 2–3 SDUs 0.563 (0.360; 0.881 0.012
  ≥ 4 SDUs 0.931 (0.415;2.092) 0.863
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(79.6%). The majority had a basic educational level, were 
overweight and did not have toxic habits.
When comparing EA-OA phenotype with subjects aged 
40 or over without OA, we observed that axial OA increased 
with age (although less markedly between 60 and 79 years) 
(Table 4). In addition, it was more frequent in women than 
men, and in the center of Spain than in the north and Medi-
terranean region. Frequency proved similar in rural and 
urban municipalities. As the level of education increased, 
EA-OA phenotype decreased. It was more frequent in obese 
and overweight patients than in normal weight subjects, with 
a significance level of 0.062 in the univariate analysis. The 
frequency of EA-OA phenotype was lower in former smok-
ers and occasional smokers, as well as in subjects who con-
sumed 2–3 SDUs per day.
In the multivariate analysis (Table 5), there was a signifi-
cant relationship between age and EA-OA phenotype; in the 
70–79 age group the increase was slightly lower than in the 
50–59 age group, with a peak in those over 80 years. EA-OA 
phenotype was more frequent in women, in central Spain, in 
people with low educational levels, as well as in obese sub-
jects. In contrast, it was less frequent in people consuming 
2–3 SDUs per day. No relationship between smoking habit 
and EA-OA phenotype was found.
Cervical OA vs lumbar OA
The prevalence of cervical OA based on clinical or clinical-
radiographic criteria was 10.10% (95% CI 9.07–11.24). By 
sex, it measured 13.90% (12.42–15.54) in women and 5.94% 
(4.62–7.60) in men. Of the 345 patients with cervical OA, 
78.3% had already been diagnosed prior to EPISER2016. 
Only in the remaining percentage were the new criteria used 
(Fig. 2). The 118 cases of cervical OA based on clinical-
radiographical criteria and without lumbar osteoarthri-
tis were mostly women (73.7%) and lived in urban areas 
(80.5%). Most had a basic educational level (56.8%), were 
overweight or obese (55.4%) and did not refer toxic habits 
(73.7% were non-smokers or ex-smokers and 84.7% did not 
consume alcohol on a daily basis) (Table 1).
The prevalence of lumbar OA based on clinical or clini-
cal-radiographic criteria was 15.52% (95% CI 14.30–16.83). 
By sex, it was 21.03% (19.29–22.88) in women and 9.48% 
(7.85–11.40) in men. Of the 540 patients with lumbar OA, 
80.6% had already been diagnosed prior to EPISER2016; 
thus, the new diagnostic criteria were applied in 19.4% of 
cases (105/540) (Fig. 2). The 310 subjects with lumbar OA 
based on clinical-radiographic criteria and without cervi-
cal osteoarthritis presented characteristics similar to those 
cases with cervical osteoarthritis and without lumbar oste-
oarthritis: most were women (75.2%), lived in an urban 
environment (79.7%), had a basic educational level, were 
overweight or obese and did not refer toxic habits (Table 1).
The univariate analysis between patients with cervical 
OA and patients with lumbar OA showed (Table 6) that the 
difference between cervical and lumbar OA (there was a 
higher frequency of the latter) increased with age, with BMI, 
in North and Central Spain versus the Mediterranean region, 
and in patients who did not smoke or who were ex-smokers; 
these increases were statistically significant. The difference 
between the frequency of lumbar and cervical OA was simi-
lar in men and women and was not influenced by the type 
Table 4  Univariate analysis of EA-OA vs subjects without OA ≥ 40 
years old
SDU standard drink unit




Age range (years)  < 0.001
 40–49 69 (7.0) 912 (93.0)
 50–59 110 (15.9) 580 (84.1)
 60–69 73 (14.8) 421 (85.2)
 70–79 40 (13.5) 256 (86.5)
  ≥ 80 27 (16.1) 141 (83.9)
Sex  < 0.001
 Men 83 (8.1) 945 (91.9)
 Women 236 (14.7) 1365 (85.3)
Region of Spain  < 0.001
 North 85 (11.2) 676 (88.8)
 Mediterranean and 
Canary Islands
104 (9.6) 979 (90.4)
 Center 130 (16.6) 655 (83.4)
Type of municipality 0.124
 Rural 65 (10.4) 561 (89.6)
 Urban 254 (12.7) 1749 (87.3)
Educational level  < 0.001
 Basic 175 (16.0) 922 (84.0)
 Medium 81 (12.2) 581 (87.8)
 Higher 63 (7.3) 805 (92.7)
Body mass index 0.062
 Normal weight 115 (10.5) 985 (89.5)
 Low weight 2 (8.7) 21 (91.3)
 Overweight 137 (13.1) 910 (86.9)
 Obese 54 (15.3) 299 (84.7)
Smoking 0.048
 Non-smoker 164 (13.7) 1036 (86.3)
 Former smoker 82 (9.8) 759 (90.2)
 Smoker 69 (12.8) 472 (87.2)
 Occasional smoker 4 (8.5) 43 (91.5)
Alcohol (daily intake) 0.001
 0 SDU 270 (13.1) 1795 (86.9)
 1 SDU 37 (11.8) 277 (88.2)
 2–3 SDUs 8 (3.8) 202 (96.2)
  ≥ 4 SDUs 4 (10.0) 36 (90.0)
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of municipality (rural or urban). It was somewhat lower in 
those with a higher educational level, but this decrease was 
not statistically significant.
In the multivariate analysis (Table 7), the difference 
between the frequency of lumbar OA and cervical OA was 
greater with increasing age (this increase was statistically 
significant in the older groups) and was not associated with 
gender. In the Mediterranean region and the Canary Islands, 
the difference between the frequency of lumbar and cer-
vical OA was less than in the north and center of Spain; 
this decrease was statistically significant. In overweight 
and obese subjects, the difference between the frequency 
of lumbar OA and cervical OA was greater than in those 
of normal weight, being statistically significant for obesity.
Discussion
In this paper, we analyzed the main characteristics of axial 
OA based on EPISER2016, a cross-sectional multicenter 
population-based study. Our data showed that the preva-
lence of axial OA based on clinical or clinical-radiographic 
Table 5  Multivariate analysis of EA-OA vs subjects without OA ≥40 
years old
SDU standard drink unit
OR (95% CI) p value
Age range (years)
 40–49
 50–59 2.128 (1.526; 2.966)  < 0.001
 60–69 1.940 (1.337;2.817)  < 0.001
 70–79 1.746 (1.109; 2.749) 0.016
  ≥ 80 2.430 (1.410;4.186) 0.001
Sex
 Women 1.706 (1.267; 2.295)  < 0.001
Region of Spain
 North
 Mediterranean and Canary 
Islands
0.824 (0.600; 1.131) 0.231
 Center 1.451 (1.062; 1.983) 0.019
Type of municipality
 Urban 1.293 (0.950; 1.759) 0.102
Educational level
 Basic
 Medium 0.807 (0.594; 1.096) 0.170
 Higher 0.494 (0.355; 0.687)  < 0.001
Body mass index
 Normal weight
 Low weight 0.676 (0.153; 2.995) 0.606
 Overweight 1.308 (0.991; 1.727) 0.058
 Obese 1.618 (1.121; 2.334) 0.010
Smoking habit
 Non-smoker
 Former smoker 0.783 (0.578; 1.061) 0.115
 Smoker 1.126 (0.808; 1.568) 0.484
 Occasional smoker 0.794 (0.274; 2.299) 0.671
Alcohol (daily intake)
 0 SDU
 1 SDU 1.049 (0.710; 1.549) 0.810
 2–3 SDUs 0.305 (0.145; 0.641) 0.002
  ≥ 4 SDUs 0.878 (0.269; 2.302) 0.662
Table 6  Univariate analysis of cervical OA vs lumbar OA
SDU standard drink unit
*Chi-squared test for each independent variable
Cervical OA Lumbar OA p value*
Age range (years) 0.012
 40–49 25 (35.2) 46 (64.8)
 50–59 41 (33.3) 82 (66.7)
 60–69 31 (29.8) 73 (70.2)
 70–79 12 (16.0) 63 (84.0)
  ≥ 80 9 (16.4) 46 (83.6)
Sex 0.760
 Men 31 (28.7) 77 (71.3)
 Women 87 (27.2) 233 (72.8)
Region of Spain 0.013
 North 27 (22) 96 (78)
 Mediterranean and 
Canary Islands
54 (36.2) 95 (63.8)
 Center 37 (23.7) 119 (76.3)
Type of municipality 0.848
 Rural 23 (26.7) 63 (73.3)
 Urban 95 (27.8) 247 (72.2)
Educational level 0.177
 Basic 67 (26.3) 188 (73.7)
 Medium 23 (24.2) 72 (75.8)
 Higher 28 (35.9) 50 (64.1)
Body mass index 0.005
 Normal weight 48 (35.6) 87 (64.4)
 Low weight 2 (100) 0
 Overweight 44 (25.9) 126 (74.1)
 Obese 18 (19.4) 75 (80.6)
Smoking habit 0.018
 Non-smoker 58 (24.7) 177 (75.3)
 Former smoker 29 (26.1) 82 (73.9)
 Smoker 31 (40.8) 45 (59.2)
 Occasional smoker 0 6 (100)
Alcohol (daily intake) 0.966
 0 SDU 100 (27.8) 260 (72.2)
 1 SDU 12 (26.7) 33 (73.3)
 2–3 SDUs 4 (23.5) 13 (76.5)
  ≥ 4 SDUs 2 (33.3) 4 (66.7)
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criteria in subjects aged 40 or more years was 19.17% (95% 
CI: 17.82–20.59). To our knowledge, this is the first data on 
axial OA (cervical and/or lumbar OA) in Spain and, as far 
as we know, the first study on the prevalence of axial OA 
in Europe.
In this project, we compared two populations of patients 
with axial OA vs subjects aged 40 years or more without 
axial OA. The first group was comprised of subjects with 
axial OA based on clinical-radiographic criteria who might 
have peripheral OA (NEA-AO phenotype, a total of 649 
cases). The second group consisted of exclusive axial OA 
(EA-AO); these were subjects with axial OA based on clin-
ical-radiographic criteria but without peripheral OA (319 
cases).
In the multivariate analysis of patients with NEA-OA 
phenotype versus subjects in the same age range without 
axial OA, OA increased with age and was more frequent 
in women. The relation between sex and axial OA is not 
clear in previous papers. In some studies, higher prevalence 
was associated with male sex [12], in others it was linked 
to female sex [13, 14], while in still others there was no 
significant difference [7, 15, 19]. This probably reflects the 
influence of different factors (ex. Genetics and racial char-
acteristics). NEA-OA phenotypes was more prevalent in 
people with a lower level of education, which could reflect 
the greater likelihood of physical labor-like work [27]. The 
prevalence was higher in the center of Spain than in the 
north or Mediterranean area. Although peripheral OA has 
been linked to geographic areas (e.g., knee OA in Africa or 
hip OA in Asia), no association has been described between 
axial OA and this factor. A lower frequency of NEA-OA 
phenotype was observed in subjects who consumed 2 to 3 
units of alcohol per day. To our knowledge, this is the first 
description of axial OA and alcohol consumption.
The same results were observed when in the multivariate 
analysis comparing subjects with EA-OA phenotype versus 
those without axial OA. The only difference between the 
two Axial OA phenotypes is that the prevalence of NEA-
OA increased significantly in those who were overweight 
or obesity, while EA-OA only increased significantly with 
obesity. These results are interesting because they suggest 
that biomechanical factors are relevant in axial OA. Lumbar 
OA was associated with obesity in other studies [12, 13]; 
e.g., Hasset et al. described an increase of lumbar OA in 
association with BMI, but with borderline significance for 
obesity [28].
Lumbar OA was more frequent than cervical OA (preva-
lence of 15.52%, 95% CI 14.30–16.83, and 10.10%, 95% 
CI 9.07–11.24, respectively). There are to the best of our 
knowledge no published data on the prevalence of axial 
OA including both cervical and lumbar OA, and data on 
the prevalence of cervical and lumbar OA, separately, are 
scarce. Both show great variability, from 3.38% to 20.46% in 
cervical OA [20, 21], and from 5.6 to 67% in lumbar OA [7, 
14]. One publication that examined lumbar OA in corpses 
showed that it was present in 100% of adults over 60 years 
of age [19]. Crude and adjusted prevalence rates of lumbar 
OA in subjects older than 18 years in Beijing was 9.02 and 
7.44%, respectively [13]. These data could not be directly 
compared with EPISER2016 because our results refer to a 
population aged 40 years or older and imaging examinations 
(radiography, computerized tomography (CT) or magnetic 
resonance) were mandatory for diagnosing lumbar osteo-
arthritis in the Chinese study. The prevalence of clinical-
radiographic axial OA in Korea was 16% in women and 5.6 
in men [14], but any comparison with EPISER2016 is also 
problematic because the former involved a population aged 
50 years or more and the pain duration used to define OA 
was more than a month (in EPISER2016 it was more than 
three months). Another Korean study based on computer-
ized tomography in people over 20 years old observed a 
radiographic lumbar OA prevalence of 20.23% in men and 
14.29% in women [15].
When comparing cervical and lumbar OA, the latter was 
more common. The difference between the two was sig-
nificantly greater in those aged 70 years or more and in the 
obese. It was also greater in northern and central Spain than 
in the Mediterranean area; we have no clear explanation for 
this result.
As regards the limitations of the study, some factors that 
could influence the prevalence of axial OA, such as the type 
of work that people do (prolonged hours in the same posi-
tion, weight bearing…) were not available for our analysis. 
The lack of validated criteria for the diagnosis of cervical 
Table 7  Multivariate analysis of cervical OA vs lumbar OA
OR (95% CI) p value
Age range (years)
 40–49
 50–59 1.033 (0.543; 1.965) 0.920
 60–69 1.207 (0.606; 2.404) 0.592
 70–79 2.381 (1.026; 5.523) 0.043
  ≥ 80 2.446 (0.963; 6.212) 0.060
Sex





0.45 (0.253; 0.800) 0.007
 Center 0.921 (0.509; 1.667) 0.785
Body mass index
 Normal weight
 Overweight 1.638 (0.974; 2.756) 0.063
 Obese 2.066 (1.076; 3.967) 0.029
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or lumbar OA was also a limitation. Lumbar OA has been 
described as typically affecting the anterior structures first 
and then later the posterior ones. There are, however, are 
atypical patterns of disease [5]. In the published articles on 
lumbar OA, it is described in relation to K-L involvement, 
according to osteophytes and the narrowing of intervertebral 
disc space [12]. However, there are no validated criteria for 
the diagnosis. For this reason, EPISER2016 clinical-radi-
ographic diagnostic criteria were defined, to include pain, 
stiffness and at least one radiological criterion (osteophytes 
or space reduction, or sclerosis in interapophyseal joints). 
These criteria were only used in patients with no prior diag-
nosis (75 subjects with cervical OA out of 345, and 105 out 
of 540 with lumbar OA). We reanalyzed the data excluding 
patients diagnosed by these new criteria, and our results did 
not differ significantly (data not shown).
Another important aspect to consider is the representa-
tiveness of  the sample. In this regard, the self-reported 
data on OA chronic cervical pain and chronic lumbar pain 
available from the 2017 National Health Survey of Spain, 
which boasts rigorous sampling procedures, are similar to 
those that were initially self-reported by the subjects in 
EPISER2016 (20.6 vs 18.4%; 17.4 vs 13.5%; 21.7 vs 18.4%, 
respectively). This would indicate that the possible reasons 
for refusing to participate in EPISER2016 were not associ-
ated with its primary objective [26, 29].
In conclusion, this is the first study on the prevalence 
of axial OA phenotypes in Europe describing the associ-
ated socio-demographic, anthropometric, and lifestyle vari-
ables. Non-Exclusive Axial OA (NEA-OA Phenotype) was 
more frequent in women, in people with a lower level of 
education and in those living in the center of Spain (versus 
the northern or Mediterranean areas). Exclusive axial OA 
(EA-OA phenotype) increased with obesity. Lumbar OA 
was more prevalent than cervical OA, this difference being 
significantly greater in adults aged 70 years or more and in 
obese subjects.
Characterizing the two axial OA phenotypes is important 
because it can help us understand the different risk factors 
associated with them as well as possible differences in the 
pathogenetic mechanisms of the two phenotypes. All of 
this can influence treatment. It will also help select patients 
for possible clinical trials. Peripheral OA and axial OA are 
clearly two phenotypes of OA. Knowing whether exclusive 
axial OA (EA-OA) is different from axial OA associated 
with peripheral OA (NEA-OA) can help us to study its risk 
factors, pathogenetic mechanisms, prognosis of the disease 
and also its correct treatment.
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